Orlistat is a lipase inhibitor that reduces intestinal fat absorption by blocking pancreatic and gastric lipases, aiding weight loss in obesity management. It matters clinically as an adjunct to diet and exercise for reducing cardiovascular risk factors linked to obesity. A key consideration is its gastrointestinal side effects, such as steatorrhea, due to unabsorbed fats.